Trial Profile
Non-Invasive Brain Imaging Techniques That Predict Antidepressant Responsiveness and Provide Insights Into the Mechanism of Action of Venlafaxine ER vs. Fluoxetine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Biomarker; Therapeutic Use
- 07 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2009 New trial record